Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-20T12:47:34.683Z Has data issue: false hasContentIssue false
  • English
  • Français

A Double-Blind Controlled Trial of a Non-Barbiturate Hypnotic—Nitrazepam

Published online by Cambridge University Press:  29 January 2018

Ijaz Haider
Ijaz Haider*
Affiliation:
University of Edinburgh Department of Psychiatry, Morningside Park, Edinburgh, 10
Get access Rights & Permissions [Opens in a new window]

Extract

The need for an acceptable, effective non-barbiturate hypnotic has long been recognized. Nitrazepam (Mogadon), an analogue of chlordiazepoxide with a chemical formula: 1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one recently became available for trial. It has been reported to be a safe and effective hypnotic (General Practitioner Research Group, Report No. 79, 1965). Peck and Shervington (1966) found 10 mg. of nitrazepam as effective as 200 mg. of amylobarbitone in general hospital patients. In a previous investigation (Haider, 1967) I reported the efficacy of nitrazepam as an hypnotic agent, in comparison to a placebo, in a group of elderly psychiatric inpatients.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 114 , Issue 508 , March 1968 , pp. 337 - 343
Copyright
Copyright © Royal College of Psychiatrists, 1968 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bailey, N. T. J. (1959). Statistical Methods in Biology. London: English Universities Press.Google Scholar
Cochran, W. G., and Cox, G. M. (1960). Experimental Designs. 2nd Ed. New York & London: L. Wiley & Sons Google Scholar
Fraser, A. G., and Shepherd, F. G. G. (1966). ‘Trial of a new hypnotic in general practice.” (General Practitioners Forum.) Practitioner, 196, 829–833.Google Scholar
General Practitioner Research Group (Report No. 79) (1965). “Sedation with a new non-barbiturate compound.” Practitioner, 195, 366–368.Google Scholar
Gogolak, G., and Pillat, B. (1965). “Effect of Mogadon on the arousal reaction in rabbits.” Progress in Brain Research, 18, 229–230.Google Scholar
Haider, I. (1967). “A safe night sedation for elderly psychiatric patients.” Med. Dig., 13, 69–71.Google Scholar
Peck, J. E., and Shervington, P. C. (1966). “Trial of a new sleep-inducing drug.” J. Therap., 1, 25–27.Google Scholar
Randall, L. O., Schallek, W., Scheckel, C., Bagdon, R. E., and Rieder, J. (1965). “Zur pharmakologie von Mogadon, einem Schlafmittel mit neuartigem Wirkungsmechanismus.” Schweiz. med. Wschr., 95, 334–337.Google Scholar
Smith, A. J. (1966). “Nitrazepam (‘Mogadon’).” Prescriber's J., 6, 31–32.Google Scholar
Snedecor, G. W. (1956). Statistical Methods. 5th Ed. Iowa State Press.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.